Latest Regulatory Engagement News

NZX Limited reported a robust first half of 2026 with operating earnings up 9.4% and net profit rising 18%. The exchange strengthened its funds management and wealth administration arms, relaunched equity derivatives, and declared a higher interim dividend. A new CEO is set to take the helm in September.

Investigator Silver has hit a key development milestone, lodging a Mining Lease Application for its Paris Silver Project in South Australia. This step follows extensive technical work and stakeholder engagement, setting the stage for approvals and project development in 2027.

Taiko Critical Minerals has successfully closed a NZ$2.5 million Share Purchase Plan, issuing over 10 million shares at NZ$0.25 each to support the development of its Barrytown Critical Minerals Project.

Vector Limited (NZX:VCT) posted a 55% jump in net profit to $240 million for FY2026, driven by a 20% rise in adjusted EBITDA and a record $544 million capital investment in Auckland’s electricity network.

Dimerix has secured full sponsorship of the US Investigational New Drug application for its Phase 2-ready kidney drug DMX-652, setting the stage for a clinical trial targeting acute kidney injury in late 2026.

Archer Materials has pinpointed a capillary blood collection method that matches venous samples in haemolysis levels, advancing its potassium Biosensor development towards integrated clinical testing.

Metallium Limited has appointed key board members and executives to strengthen governance and operational capacity as it advances its Flash Joule Heating technology towards commercialisation in the US.

AdAlta’s lead CAR-T therapy EW-001 continues to demonstrate encouraging survival and response rates in its mesothelioma study, with all patients alive at the latest follow-up and stronger outcomes at higher doses supporting plans for an Australian Phase 1 trial.

American Tungsten & Antimony plans to restart and expand the Del Sol Refinery and White Spar Mine in the US, contingent on completing their acquisition. The company is preparing for increased processing capacity and new product lines while engaging with regulators and engineering firms.

Strata Minerals is pushing forward multiple technical workstreams at its Zelica Gold Project in Western Australia, backed by BML Ventures. These initiatives aim to de-risk mine planning, processing, and permitting as the project moves closer to development.

Neurotech International has secured $4.5 million through a share placement to fund its pivotal Phase III clinical trial of NTI164 for Autism Spectrum Disorder, aiming to reach topline data readout.

Hot Chili Limited expands its Costa Fuego copper-gold project with significant drilling success at La Verde, underpinning a strong Preliminary Feasibility Study and strategic water infrastructure plans.